ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

In Brief: LEO Sachs To Receive 1983 Bristol-Myers Award; 50 Percent Current Rate Achievable Now: Tylor

April 1, 1983

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994

Clinton to Propose Increase for NIH & NCI Significantly Higher Than In Previous Years

January 9, 1998

In Brief: Shubik, Rhoads, Dixon Affiliations With Industry Lister By House Subcommittee

June 11, 1976

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001